British drugmaker AstraZeneca Plc and French biopharmaceutical firm Transgene SA entered into an agreement on Thursday to co-develop five cancer-killing viral immunotherapies.
from Reuters: Health News https://reut.rs/2ZOwHEJ
via IFTTT
Thursday, May 2, 2019
Home »
Reuters: Health News
» AstraZeneca ties up with France's Transgene to develop viral immunotherapies
0 comments:
Post a Comment